Literature DB >> 16947385

Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis.

Heiner Appel1, Maren Kuhne, Simone Spiekermann, Harald Ebhardt, Zarko Grozdanovic, Dorothee Köhler, Marc Dreimann, Axel Hempfing, Martin Rudwaleit, Harald Stein, Peter Metz-Stavenhagen, Joachim Sieper, Christoph Loddenkemper.   

Abstract

OBJECTIVE: Zygapophyseal joints of the spine are often affected in ankylosing spondylitis (AS). In this study, we undertook a systematic immunohistologic evaluation of the immunopathology of the zygapophyseal joints in patients with advanced AS.
METHODS: We obtained zygapophyseal joints from 16 AS patients undergoing polysegmental correction of kyphosis and from 10 non-AS controls (at autopsy). Immunohistologic analysis of the bone marrow was performed by analyzing the number of infiltrating T cells (CD3, CD4, CD8), B cells (CD20), osteoclasts (CD68), bone marrow macrophages (CD68), and microvessel density (CD34) per high-power field.
RESULTS: Zygapophyseal joints from 6 of 16 AS patients, but from none of the controls, exhibited 2 or more CD3+ T cell aggregates, signifying persistent inflammation. Interstitial CD4+ and CD8+ T cells were significantly more frequent in AS patients compared with non-AS controls (P = 0.002 and P = 0.049, respectively). While there was no clear difference between the number of CD20+ B cells in AS patients overall compared with controls, there was a significant difference when persistently inflamed joints from patients with AS were compared with joints without active inflammation from patients with AS or joints from controls (both P = 0.03). Microvessel density in bone marrow from AS patients with active inflammation was significantly higher than that in bone marrow from controls.
CONCLUSION: This immunohistologic study of bone marrow from zygapophyseal joints demonstrates persistent inflammation in the spine of patients with AS, including those with longstanding disease. The findings of increased numbers of T cells and B cells and neoangiogenesis suggest that these features play a role in the pathogenesis of AS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947385     DOI: 10.1002/art.22060

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  44 in total

Review 1.  Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature.

Authors:  Mohammed A Omair; Khalid A Alnaqbi; Peter Lee
Journal:  Clin Rheumatol       Date:  2012-05-27       Impact factor: 2.980

2.  Overexpression and unique rearrangement of VH2 transcripts in immunoglobulin variable heavy chain genes in ankylosing spondylitis patients.

Authors:  Yeon Joo Kim; Na Young Kim; Min Kyung Lee; Hyo Jin Choi; Han Joo Baek; Chang Hoon Nam
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

Review 3.  [Ankylosing spondylitis--current state of imaging including scoring methods].

Authors:  C E Althoff; K G Hermann; J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 4.  Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.

Authors:  Smriti K Raychaudhuri; Ankit Saxena; Siba P Raychaudhuri
Journal:  Clin Rheumatol       Date:  2015-05-05       Impact factor: 2.980

5.  Entheses and bones in spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).

Authors:  Robert A Colbert; Atul A Deodhar; David Fox; Ellen M Gravallese; Muhammad Asim Khan; Dennis McGonagle; John D Reveille; Georg Schett; Michael Weisman; Daniel O Clegg
Journal:  J Rheumatol       Date:  2009-07       Impact factor: 4.666

6.  Osteoporosis: a paradox in ankylosing spondylitis.

Authors:  Shea Carter; Rik J Lories
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

Review 7.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 8.  Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

Authors:  Lode Melis; Dirk Elewaut
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

Review 9.  Opinion: Perspectives on imaging in axial spondyloarthritis.

Authors:  Xenofon Baraliakos; Jürgen Braun
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

10.  Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging.

Authors:  Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Laura M Calvi; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.